Montanari Vergallo Gianluca, Spagnolo Antonio G
Department of Anatomical, Histological, Medico-Legal and Orthopaedic Sciences, "Sapienza" University of Rome, Rome, Italy.
Institute of Bioethics and Medical Humanities, School of Medicine, Catholic University of the Sacred Heart, Rome, Italy.
Linacre Q. 2019 May;86(2-3):188-197. doi: 10.1177/0024363919837863. Epub 2019 Mar 29.
This article's authors delve into, and comment on, some of the key provisions within law no. 219, passed in 2017, which came into full effect in 2018. The legislation presents several innovative aspects: (a) communication time is equated to care; (b) patients may turn down lifesaving treatments, yet doctors must put in place all suitable support processes, from a psychological standpoint as well, in order to make sure that patients make informed decisions in full awareness; (c) refusal to treatment may be expressed prior to the onset of the disease making the patient incapable, as long as the advance directive is laid out by a mentally capable adult who has been provided with all relevant medical information available as to the consequence of a refusal to undergo a given treatment; (d) artificial nutrition and hydration are tantamount to treatment; thus, they may not be carried out and kept in place in absence of valid consent; (e) patients may appoint a healthcare proxy holder, tasked with interacting with doctors and caregivers and expressing consent or refusal; (f) patient will, whether current or advance, must be complied with even under emergency or urgency conditions, provided that clinical conditions and circumstances make it possible to acquire it; (g) doctors may disregard advance directives only when specifically provided for by the law; (h) patients may not demand treatment deemed to be illegal or running counter to ethical codes or scientific evidence. The new legislation, therefore, is meant to uphold the right to exercise self-determination as well as the patient's quality of life, yet ensuring that doctors remain fully capable of making the decisions that they are best positioned to. The Italian Parliament has for the first time regulated the issue of consent and refusal of healthcare treatments, whether currently expressed or advance. This article elaborates on recent Italian legislation that details a patient's right to consent to or refuse treatment in advance, including refusal of artificial nutrition and hydration, the duty of doctors in the event of an emergency, the shared planning treatment, the role of durable power of attorney, and advance healthcare directives.
本文作者深入探讨并评论了2017年通过、2018年全面生效的第219号法律中的一些关键条款。该立法呈现出几个创新方面:(a)沟通时间等同于护理;(b)患者可以拒绝救命治疗,但医生必须从心理角度等方面落实所有适当的支持程序,以确保患者在充分知情的情况下做出明智决定;(c)只要预先指示由具备精神能力的成年人制定,且该成年人已获得关于拒绝接受特定治疗后果的所有可用相关医疗信息,那么在疾病使患者丧失行为能力之前就可以表达拒绝治疗的意愿;(d)人工营养和水合等同于治疗;因此,在没有有效同意的情况下不得进行和维持;(e)患者可以指定一名医疗保健代理人,负责与医生和护理人员互动并表达同意或拒绝;(f)即使在紧急或紧迫情况下,只要临床状况和情况允许获取患者意愿,就必须遵守患者当前或预先的意愿;(g)只有在法律有明确规定时,医生才可无视预先指示;(h)患者不得要求被视为非法或违背道德规范或科学证据的治疗。因此,新立法旨在维护患者行使自我决定权的权利以及生活质量,同时确保医生仍完全有能力做出他们最有资格做出的决定。意大利议会首次对医疗治疗的同意和拒绝问题进行了规范,无论是当前表达的还是预先表达的。本文详细阐述了意大利最近的立法,该立法详细规定了患者提前同意或拒绝治疗的权利,包括拒绝人工营养和水合、紧急情况下医生的职责、共同规划治疗、持久授权书的作用以及预先医疗指示。